|
OMIM |
Link |
Information gain |
01 |
|
singleton-merten syndrome
|
[NCBI]
|
0.0029656
|
|
|
calcific aortic disease with immunologic abnormalities, familial
|
[NCBI]
|
0.000639161
|
|
|
aortic valve disease
|
[NCBI]
|
0.000361902
|
|
|
APOE
|
[NCBI]
|
0.000266452
|
|
|
GACI
|
[NCBI]
|
0.000237787
|
|
|
MFS
|
[NCBI]
|
0.000178818
|
|
|
SVAS
|
[NCBI]
|
0.000173307
|
|
|
gaucher disease, type iiic
|
[NCBI]
|
7.80613e-05
|
|
|
takayasu arteritis
|
[NCBI]
|
7.42375e-05
|
|
|
epstein syndrome
|
[NCBI]
|
7.26201e-05
|
|
|
TMBIM1
|
[NCBI]
|
6.48113e-05
|
|
|
LPL
|
[NCBI]
|
5.32013e-05
|
|
|
RA
|
[NCBI]
|
5.3172e-05
|
|
|
SLC22A6
|
[NCBI]
|
5.17332e-05
|
|
|
TXN
|
[NCBI]
|
5.17332e-05
|
|
|
ADM
|
[NCBI]
|
5.11718e-05
|
|
|
TNFRSF11B
|
[NCBI]
|
4.98914e-05
|
|
|
temporal arteritis
|
[NCBI]
|
4.80835e-05
|
|
|
TXNIP
|
[NCBI]
|
4.44121e-05
|
|
|
RSTS
|
[NCBI]
|
4.42846e-05
|
|
|
GATA4
|
[NCBI]
|
4.28246e-05
|
|
|
MMP12
|
[NCBI]
|
4.28246e-05
|
|
|
IL1B
|
[NCBI]
|
3.91898e-05
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
3.64179e-05
|
|
|
BTC
|
[NCBI]
|
3.58009e-05
|
|
|
PDGFB
|
[NCBI]
|
3.51102e-05
|
|
|
PLN
|
[NCBI]
|
3.51102e-05
|
|
|
CLU
|
[NCBI]
|
3.04402e-05
|
|
|
FGF23
|
[NCBI]
|
3.00374e-05
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
2.89929e-05
|
|
|
WBS
|
[NCBI]
|
2.61645e-05
|
|
|
SRF
|
[NCBI]
|
2.60641e-05
|
|
|
SPP1
|
[NCBI]
|
2.58135e-05
|
|
|
antithrombin iii deficiency
|
[NCBI]
|
2.34731e-05
|
|
|
PON1
|
[NCBI]
|
2.30879e-05
|
|
|
PDCD8
|
[NCBI]
|
1.97983e-05
|
|
|
PTH
|
[NCBI]
|
1.59305e-05
|
|
|
LDLR
|
[NCBI]
|
1.54829e-05
|
|
|
PF4
|
[NCBI]
|
1.16492e-05
|
|
|
CTGF
|
[NCBI]
|
1.16001e-05
|
|
|
FRAP1
|
[NCBI]
|
1.07452e-05
|
|
|
VEGF
|
[NCBI]
|
8.34409e-06
|
|
|
TNF
|
[NCBI]
|
6.29807e-06
|
|
|
MPO
|
[NCBI]
|
5.82792e-06
|
|
|
TNFSF6
|
[NCBI]
|
4.23359e-06
|
|
|
SLE
|
[NCBI]
|
4.15703e-06
|
|
|
F3
|
[NCBI]
|
3.51904e-06
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
3.33264e-06
|
|
|
MG
|
[NCBI]
|
1.54562e-06
|
|
|
HGF
|
[NCBI]
|
1.34516e-06
|
|
|
AVP
|
[NCBI]
|
8.10673e-07
|
|
|
AD
|
[NCBI]
|
1.06054e-08
|
|
|
PCNA
|
[NCBI]
|
1.81763e-09
|
|